- Home
- PROK vs FRGE Comparison
PROK vs FRGE Comparison
Compare PROK & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | FRGE |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 354.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | FRGE |
|---|---|---|
| Price | $2.21 | $44.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | $6.25 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 1.2M | 582.5K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $744,000.00 | ★ $92,884,000.00 |
| Revenue This Year | $918.66 | $33.10 |
| Revenue Next Year | N/A | $24.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.40 |
| 52 Week Low | $0.46 | $6.60 |
| 52 Week High | $7.13 | $44.76 |
Technical Indicators
Market Signals| Indicator | PROK | FRGE |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 85.10 |
| Support Level | $2.06 | $44.30 |
| Resistance Level | $2.29 | $44.41 |
| Average True Range (ATR) | 0.17 | 0.13 |
| MACD | 0.01 | -0.86 |
| Stochastic Oscillator | 23.77 | 93.40 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.